Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

HOLISTA COLLTECH LIMITED Major Shareholding Notification 2015

Oct 22, 2015

65044_rns_2015-10-22_1f5e8d76-7e07-436d-a28c-9bf52d2c0f89.pdf

Major Shareholding Notification

Open in viewer

Opens in your device viewer

==> picture [209 x 48] intentionally omitted <==

Holista CollTech Limited

(ASX:HCT / ABN 24 094 515 992) Suite 12, Level 1, 11 Ventnor Avenue, WEST PERTH WA 6005 Ph: +618-6141-3500 Fax: +618-6141-5999 www.holistaco.com

23 October 2015

Proposed Change in Substantial Holder

Holista CollTech Limited ( ASX: HCT ) ( Holista or the Company ) advises that it has received notice from the Company’s Chairman and largest shareholder, Dr. Rajendran Marnickavasagar ( Dr Rajen ) in relation to a proposed sale by Dr Rajen of 58,514,245 fully paid ordinary shares in Holista ( Shares ) to Galen Bio Medical Inc. ( Purchaser ) ( Proposed Transaction ). The Purchaser is a company incorporated in the state of Delaware, USA and is a private holding company regulated by the Financial Industry Regulatory Authority of USA.

As part of the Proposed Transaction, Dr Rajen will acquire a 75% interest in the Purchaser and will also become a Director of the Purchaser. On completion of the Proposed Transaction Galen Bio Medical Inc., will be the registered holder of a 38% interest in Holista. Dr Rajen will remain as the registered holder of a 10% interest in the Company.

Completion of the Proposed Transaction is subject to the Company and the Purchaser obtaining all required regulatory and shareholder approvals. The proposed share acquisition by the Purchaser will, if approved by the Company's shareholders, result in the Purchaser and its associates (within the meaning in the Corporations Act) obtaining voting power in more than 20% of the total issued voting shares in the capital of the Company. As a result, the Company will seek approval from shareholders of the Company in accordance with item 7 of the table in Section 611 of the Corporations Act.

It is proposed Dr Rajen will remain as the CEO and Chairman of Holista. There will be no other changes to the Board of Holista. The Board considers completion of the Proposed Transaction will not have any major impact on the underlying ownership, direction or operation of the Company. The Company Notice of Annual General Meeting includes further details of the Proposed Transaction.

Jay Stephenson COMPANY SECRETARY

1